HomeInsightsStock Comparison

Aurobindo Pharma Ltd vs Chandra Bhagat Pharma Ltd Stock Comparison

Aurobindo Pharma Ltd vs Chandra Bhagat Pharma Ltd Stock Comparison

Last Updated on: Jul 22, 2025

Key Highlights

  • The Latest Trading Price of Aurobindo Pharma Ltd is ₹ 1101 as of 22 Jul 15:30.
  • The P/E Ratio of Aurobindo Pharma Ltd changed from 8.5 on March 2020 to 20.1 on March 2024 . This represents a CAGR of 18.78% over 5 yearsThe P/E Ratio of Chandra Bhagat Pharma Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Aurobindo Pharma Ltd changed from ₹ 24202 crore on March 2020 to ₹ 63835 crore on March 2024 . This represents a CAGR of 21.41% over 5 yearsThe Market Cap of Chandra Bhagat Pharma Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The revenue of Aurobindo Pharma Ltd for the Mar '25 is ₹ 8516 crore as compare to the Dec '24 revenue of ₹ 8137 crore. This represent the growth of 4.66% The revenue of Chandra Bhagat Pharma Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Aurobindo Pharma Ltd for the Mar '25 is ₹ 1894 crore as compare to the Dec '24 ebitda of ₹ 1736 crore. This represent the growth of 9.08% The ebitda of Chandra Bhagat Pharma Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Aurobindo Pharma Ltd changed from ₹ 569.71 crore to ₹ 902.83 crore over 8 quarters. This represents a CAGR of 25.89% The net profit of Chandra Bhagat Pharma Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Aurobindo Pharma Ltd changed from 9.37 % on March 2020 to 13.49 % on March 2024 . This represents a CAGR of 7.56% over 5 yearsThe Dividend Payout of Chandra Bhagat Pharma Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Aurobindo Pharma Ltd

  • Aurobindo Pharma Limited (APL), one of the world's top 5 manufacturers of semi synthetic penicillins was incorporated in 26th December 1986 as a private limited company.
  • Mr. P.V.Ramaprasad Reddy, Mr. K.Nityananda Reddy and a small, highly committed group of professionals founded it.
  • APL is developing, manufacturing and marketing active pharmaceutical ingredients (APIs also referred as bulk actives), intermediates and generic formulations.
  • The company's robust product portfolio is spread over 6 major product areas encompassing (Antibiotics, Anti-Retro Virals, CVS, CNS, Gastroenterologicals, and Anti-Allergics) with around 65 APIs in the non-antibiotics and over 55 APIs in the antibiotic segment and the World Health Organization (WHO), Geneva, has also approved Aurobindo's products.
  • APL is running with 24 manufacturing plants across the world conforming to GMP/ISO regulations and an extremely well equipped 9 R&D facilities.

About Chandra Bhagat Pharma Ltd

  • Chandra Bhagat Pharma Limited was incorporated as a Private Limited Company with the name 'Chandra Bhagat Pharma Private Limited' at Mumbai on March 10, 2003.
  • Consequent upon the conversion of the Company from Private Limited Company to Public Limited Company, the name of the Company was changed to 'Chandra Bhagat Pharma Limited' on March 20, 2019. The Company incorporated in March, 2003 by Mr. Hemant Bhagat and Late.
  • Shree Chandravadan Bhagat.
  • On April 1, 2003, the Company acquired the going concern business of M/s.
  • Chandra Bhagat Corporation, partnership firm along with all its assets and liabilities.

Aurobindo Pharma Ltd News Hub

News

Aurobindo Pharma Ltd drops for fifth straight session

Aurobindo Pharma Ltd fell for a fifth straight session today. The stock is quoting at Rs 1...

Read more

11 Jul 2025 13:35

News

CuraTeQ Biologics receives European marketing authorization for biosimilar Dazublys'

CuraTeQ Biologics s.r.o., a wholly owned step-down subsidiary of Aurobindo Pharma, has obt...

Read more

02 Jul 2025 18:36

News

Lyfius Pharma re-starts production at its Penicillin-G manufacturing facility

Aurobindo Pharma announced that its wholly owned step-down subsidiary, Lyfius Pharma has r...

Read more

30 Jun 2025 09:29

News

Aurobindo Pharma Ltd spurts 0.22%, up for fifth straight session

Aurobindo Pharma Ltd is up for a fifth straight session today. The stock is quoting at Rs ...

Read more

26 Jun 2025 13:00

News

Aurobindo Pharma gets UK MHRA approval for neutropenia treatment drug Dyrupeg

Dyrupeg contains the active substance pegfilgrastim and is a biological medicine. It is a ...

Read more

25 Jun 2025 12:51

News

CuraTeQ Biologics receives UK MHRA approval for biosimilar Dyrupeg'

Aurobindo Pharma announced that CuraTeQ Biologics s.r.o., a wholly owned step-down subsidi...

Read more

24 Jun 2025 19:01

Chandra Bhagat Pharma Ltd News Hub

News

Chandra Bhagat Pharma to conduct board meeting

Chandra Bhagat Pharma will hold a meeting of the Board of Directors of the Company on 29 M...

Read more

26 May 2025 18:43

News

Chandra Bhagat Pharma schedules board meeting

Chandra Bhagat Pharma will hold a meeting of the Board of Directors of the Company on 13 N...

Read more

11 Nov 2024 13:48

News

Chandra Bhagat Pharma to conduct AGM

Chandra Bhagat Pharma announced that the Annual General Meeting (AGM) of the company will ...

Read more

13 Sep 2024 11:49

News

Chandra Bhagat Pharma schedules AGM

Chandra Bhagat Pharma announced that the Annual General Meeting (AGM) of the company will ...

Read more

13 Sep 2024 11:41

News

Chandra Bhagat Pharma to declare Quarterly Result

Chandra Bhagat Pharma will hold a meeting of the Board of Directors of the Company on 30 M...

Read more

28 May 2024 15:32

News

Chandra Bhagat Pharma to declare Quarterly Result

Chandra Bhagat Pharma will hold a meeting of the Board of Directors of the Company on 9 No...

Read more

06 Nov 2023 20:02

SWOT Analysis Of Aurobindo Pharma Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Chandra Bhagat Pharma Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Aurobindo Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Chandra Bhagat Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Aurobindo Pharma Ltd and Chandra Bhagat Pharma Ltd

Which company has a larger market capitalization, Aurobindo Pharma Ltd or Chandra Bhagat Pharma Ltd?

Market cap of Aurobindo Pharma Ltd is 64,523 Cr while Market cap of Chandra Bhagat Pharma Ltd is 43 Cr

What are the key factors driving the stock performance of Aurobindo Pharma Ltd and Chandra Bhagat Pharma Ltd?

The stock performance of Aurobindo Pharma Ltd and Chandra Bhagat Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aurobindo Pharma Ltd and Chandra Bhagat Pharma Ltd?

As of July 22, 2025, the Aurobindo Pharma Ltd stock price is INR ₹1101.2. On the other hand, Chandra Bhagat Pharma Ltd stock price is INR ₹57.95.

How do dividend payouts of Aurobindo Pharma Ltd and Chandra Bhagat Pharma Ltd compare?

To compare the dividend payouts of Aurobindo Pharma Ltd and Chandra Bhagat Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions